Published in Virology on July 24, 2012
Oncolytic viruses: From bench to bedside with a focus on safety. Hum Vaccin Immunother (2015) 1.01
Development and application of reporter-expressing mononegaviruses: current challenges and perspectives. Antiviral Res (2014) 0.83
Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular Virology. Viruses (2016) 0.75
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
Crystal structure of the Aequorea victoria green fluorescent protein. Science (1996) 16.81
THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE. Mutat Res (1964) 11.15
Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A (1995) 9.08
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell (1992) 5.72
Nucleotide sequence heterogeneity of an RNA phage population. Cell (1978) 5.55
Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc Natl Acad Sci U S A (1992) 4.22
Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. J Virol (1990) 3.93
Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A (1995) 2.60
Vesicular stomatitis virus: re-inventing the bullet. Trends Mol Med (2004) 2.42
High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol (1989) 2.04
VSV-tumor selective replication and protein translation. Oncogene (2005) 1.88
The evolution of RNA viruses: A population genetics view. Proc Natl Acad Sci U S A (2000) 1.84
The red queen reigns in the kingdom of RNA viruses. Proc Natl Acad Sci U S A (1994) 1.83
Prospects for immunisation against Marburg and Ebola viruses. Rev Med Virol (2010) 1.77
Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology (2001) 1.68
Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J Virol (2006) 1.53
Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions. J Virol (1998) 1.43
Mechanism and energetics of green fluorescent protein chromophore synthesis revealed by trapped intermediate structures. Proc Natl Acad Sci U S A (2003) 1.41
Density-dependent selection in vesicular stomatitis virus. J Virol (2004) 1.37
Evolutionarily related Sindbis-like plant viruses maintain different levels of population diversity in a common host. J Virol (2000) 1.34
Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc Natl Acad Sci U S A (2006) 1.32
A full-length cDNA infectious clone of North American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the Nsp2 region. J Virol (2006) 1.27
Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase. J Mol Biol (1989) 1.23
The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J Virol (2009) 1.19
Contributions of vesicular stomatitis virus to the understanding of RNA virus evolution. Curr Opin Microbiol (2003) 1.16
Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression. J Virol (2002) 1.15
Evolution of fitness in experimental populations of vesicular stomatitis virus. Genetics (1996) 1.11
Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages. J Virol (2004) 1.07
Phosphorylation of vesicular stomatitis virus phosphoprotein P is indispensable for virus growth. J Virol (2004) 1.05
Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles. J Virol (2005) 1.04
The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J Virol (2008) 1.02
Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases. Curr HIV Res (2003) 1.02
Biarsenical labeling of vesicular stomatitis virus encoding tetracysteine-tagged m protein allows dynamic imaging of m protein and virus uncoating in infected cells. J Virol (2009) 1.00
Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression. J Virol (2011) 0.99
Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses. Virology (2001) 0.94
Expression and stability of foreign tags inserted into nsp2 of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res (2007) 0.93
Rapid adaptive amplification of preexisting variation in an RNA virus. J Virol (2008) 0.93
Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line. J Virol (2006) 0.91
Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein. J Virol (2004) 0.90
Development of genetic markers in the non-structural protein 2 region of a US type 1 porcine reproductive and respiratory syndrome virus: implications for future recombinant marker vaccine development. J Gen Virol (2008) 0.86
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer. Chin J Cancer (2011) 0.79
Mutants with altered DNA base composition in Bacterium paracoli--the evidence from a marker. Z Allg Mikrobiol (1971) 0.76
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity (2007) 3.38
Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat Immunol (2012) 1.83
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A (2011) 1.73
Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation. J Virol (2009) 1.55
Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J Virol (2006) 1.53
Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol (2006) 1.31
RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A (2011) 1.19
The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J Virol (2009) 1.19
Replication-incompetent influenza A viruses that stably express a foreign gene. J Gen Virol (2011) 1.12
A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching. Genes Dev (2013) 1.09
Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. J Gen Virol (2006) 1.09
Phosphorylation of vesicular stomatitis virus phosphoprotein P is indispensable for virus growth. J Virol (2004) 1.05
Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles. J Virol (2005) 1.04
Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology (2006) 1.02
The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J Biol Chem (2004) 1.00
Biarsenical labeling of vesicular stomatitis virus encoding tetracysteine-tagged m protein allows dynamic imaging of m protein and virus uncoating in infected cells. J Virol (2009) 1.00
Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression. J Virol (2011) 0.99
The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA. Traffic (2008) 0.99
Single-amino-acid alterations in a highly conserved central region of vesicular stomatitis virus N protein differentially affect the viral nucleocapsid template functions. J Virol (2009) 0.99
Identification of virulence determinants of porcine reproductive and respiratory syndrome virus through construction of chimeric clones. Virology (2008) 0.99
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model. Vaccine (2013) 0.99
Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. J Virol (2011) 0.96
Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus. Virus Res (2012) 0.96
Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice. Clin Immunol (2012) 0.94
Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice. Vaccine (2013) 0.90
Construction of a full-length cDNA infectious clone of a European-like Type 1 PRRSV isolated in the U.S. Adv Exp Med Biol (2006) 0.90
Porcine reproductive and respiratory syndrome virus non-structural protein 1 suppresses tumor necrosis factor-alpha promoter activation by inhibiting NF-κB and Sp1. Virology (2010) 0.88
Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. J Virol (2013) 0.88
Induction of stress granule-like structures in vesicular stomatitis virus-infected cells. J Virol (2012) 0.88
Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response. Virology (2010) 0.87
Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1. Virology (2012) 0.87
Cellular poly(c) binding proteins 1 and 2 interact with porcine reproductive and respiratory syndrome virus nonstructural protein 1β and support viral replication. J Virol (2011) 0.85
Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1. Virol J (2008) 0.84
Development of a porcine reproductive and respiratory syndrome virus differentiable (DIVA) strain through deletion of specific immunodominant epitopes. Vaccine (2008) 0.84
Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol (2007) 0.83
Therapeutic hypothermia cardioprotection in murine hemorrhagic shock/resuscitation differentially affects p38α/p38γ, Akt, and HspB1. J Trauma (2011) 0.82
A virulent strain of porcine reproductive and respiratory syndrome virus does not up-regulate interleukin-10 levels in vitro or in vivo. Virus Res (2010) 0.81
Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation. Resuscitation (2010) 0.81
Heterogeneous nuclear ribonucleoprotein K supports vesicular stomatitis virus replication by regulating cell survival and cellular gene expression. J Virol (2013) 0.79
Amino acid residues in the non-structural protein 1 of porcine reproductive and respiratory syndrome virus involved in down-regulation of TNF-α expression in vitro and attenuation in vivo. Virology (2012) 0.79
A model for the dynamic nuclear/nucleolar/cytoplasmic trafficking of the porcine reproductive and respiratory syndrome virus (PRRSV) nucleocapsid protein based on live cell imaging. Virology (2008) 0.77
Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125. J Virol (2012) 0.77
Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus. Vaccine (2013) 0.76
Correction: Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity. PLoS One (2015) 0.75
Biarsenical labeling of tetracysteine-tagged proteins for tracking existing and newly synthesized pools of proteins. Cold Spring Harb Protoc (2009) 0.75